|
|
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells
Cedric Pastoret
,
Fabienne Desmots-Loyer
,
Gaelle Drillet
,
Simon Le Gallou
,
Marie-Laure Boulland
et al.
Journal articles
hal-03134940v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
Benoit Tessoulin
,
P Ceballos
,
P. Chevallier
,
Didier Blaise
,
Olivier Tournilhac
et al.
Journal articles
inserm-01419584v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill
,
Catherine Thieblemont
,
Lucie Oberic
,
Anne Moreau
,
Krimo Bouabdallah
et al.
Journal articles
hal-02329536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
Romain Guièze
,
Pauline Robbe
,
Ruth Clifford
,
Sophie De Guibert
,
Bruno Pereira
et al.
Journal articles
hal-01263113v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun
,
Sophie Cereja
,
Sylvie Chevret
,
Emmanuel Raffoux
,
Marie Beaumont
et al.
Journal articles
hal-01237097v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.
Benoît Bareau
,
Jérôme Rey
,
Mohamed Hamidou
,
Jean Donadieu
,
Jeff Morcet
et al.
Journal articles
hal-00744223v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
Francoise Kraeber-Bodere
,
Amandine Pallardy
,
Hervé Maisonneuve
,
Loïc Campion
,
Anne Moreau
et al.
Journal articles
hal-02425339v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
Sophie Michallet
,
Arnaud Campidelli
,
Helene Lequeu
,
Marie-Sarah Dilhuydy
,
Olivier Tournilhac
et al.
Journal articles
hal-01653723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.
Alexandre Janel
,
Frédérique Dubois-Galopin
,
Céline Bourgne
,
Juliette Berger
,
Karin Tarte
et al.
Journal articles
hal-01058950v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Emilie Reboursiere
,
Fabien Le Bras
,
Charles Herbaux
,
Emmanuel Gyan
,
Aline Clavert
et al.
Journal articles
hal-01475957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS.
Roch Houot
,
Steven Le Gouill
,
Mario Ojeda Uribe
,
C. Mounier
,
Stéphane Courby
et al.
Journal articles
hal-00744066v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
Rémy Gressin
,
Sylvie Caulet-Maugendre
,
Eric Deconinck
,
Olivier Tournilhac
,
Emmanuel Gyan
et al.
Journal articles
inserm-00508037v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency
Hélène Coignard-Biehler
,
Nizar Mahlaoui
,
Benoît Pilmis
,
Vincent Barlogis
,
Pauline Brosselin
et al.
Journal articles
hal-02377907v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
Hervé Tilly
,
Franck Morschhauser
,
Olivier Casasnovas
,
Thierry Jo Molina
,
Pierre Feugier
et al.
Journal articles
hal-02329073v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group
Lionel Adès
,
Xavier Thomas
,
Agnes Cuerci-Bres
,
Raffoux Emmanuel
,
Olivier Spertini
et al.
Blood, 2015, 126 (23), pp.451
Journal articles
hal-01300812v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia
Caroline Dartigeas
,
Eric van den Neste
,
Christian Berthou
,
Hervé Maisonneuve
,
Stéphane Leprêtre
et al.
Journal articles
hal-01272930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study
Caroline Dartigeas
,
Eric van den Neste
,
Julie Léger
,
Hervé Maisonneuve
,
Christian Berthou
et al.
Journal articles
hal-01712402v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
Thomas Hueso
,
Thomas Gastinne
,
Sylvain Garciaz
,
Emmanuelle Tchernonog
,
Caroline Delette
et al.
Journal articles
hal-02500667v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL
Norbert Schmitz
,
Lorenz Truemper
,
Krimo Bouabdallah
,
Marita Ziepert
,
Mathieu Leclerc
et al.
Journal articles
hal-03163608v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
Laurence De Leval
,
Marie Parrens
,
Fabien Le Bras
,
Jean-Philippe Jais
,
Virginie Fataccioli
et al.
Journal articles
hal-01301144v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Large granular lymphocytic leukemia associated with Lambert-Eaton Myasthenic Syndrome: A case report.
Richard Lemal
,
Carine Chaleteix
,
Patrice Minard
,
Corinne Roche
,
Jacques-Olivier Bay
et al.
Journal articles
hal-00974560v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
R-CHOP 14 with or without radiotherapy in non-bulky limited-stage diffuse large B-cell lymphoma (DLBCL)
Thierry Lamy
,
Gandhi Damaj
,
Pierre Soubeyran
,
Emmanuel Gyan
,
Guillaume Cartron
et al.
Journal articles
hal-01635792v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry
Nizar Mahlaoui
,
Capucine Picard
,
Perrine Bach
,
Laurence Costes
,
Virginie Courteille
et al.
Journal articles
hal-02015219v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|